Interpretation Bias Modification for Body Dysmorphic Disorder

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether a computerized intervention designed to reduce appearance and evaluation related interpretation biases will reduce symptoms associated with body dysmorphic disorder.

Clinical Trial Description

The present study aims to examine the feasibility of a remote treatment for body dysmorphic disorder delivered via the Internet. To evaluate the efficacy of the IBM protocol we have developed in reducing negative appearance and evaluative related interpretations, we will conduct a two-arm randomized controlled trial over the internet. Individuals with a diagnosis of body dysmorphic disorder (N = 40) will be randomized to one of two conditions: 1) IBM or 2) progressive muscle relaxation. Each condition will consist of eight 10-25 minute treatment sessions. Participants will complete two sessions per week for four weeks and will be administered assessments at pre-treatment, one week post-treatment and at 3-month follow-up. We hypothesize that: 1) IBM will lead to greater reductions in BDD symptoms than the PMR condition; 2) IBM will lead to greater reductions in depression, anxiety and suicidal ideation than the PMR condition; 3) IBM will lead to greater reductions in threat interpretations and greater increases in benign interpretations than the PMR condition; 4) The effects of condition on BDD symptoms will be mediated by changes in BDD-related interpretation bias; and 5) The effects of training in the IBM condition will be maintained at the 3-month follow-up assessments. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02635152
Study type	Interventional
Source	Florida State University
Contact
Status	Completed
Phase	N/A
Start date	September 2015
Completion date	March 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03673046` - Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)	N/A
Recruiting	`NCT05402475` - Online Cognitive Behavioural Therapy Intervention for Body Dysmorphic Disorder	N/A
Withdrawn	`NCT02843451` - Milk Thistle in Body Dysmorphic Disorder	Phase 2
Completed	`NCT02010619` - Internet Delivered CBT for Body Dysmorphic Disorder	N/A
Completed	`NCT00842309` - D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder	Early Phase 1
Completed	`NCT00245635` - Fluoxetine in Pediatric Body Dysmorphic Disorder	Phase 4
Completed	`NCT02808702` - Brain Correlates of Self-Focused Processing	N/A
Completed	`NCT01002326` - Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder	N/A
Active, not recruiting	`NCT01075672` - Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals	N/A
Completed	`NCT02671266` - Oxytocin Administration in BDD and OCD	Phase 2
Completed	`NCT01038128` - An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder	N/A
Completed	`NCT01398865` - Escitalopram Neuroimaging Supplement	N/A
Completed	`NCT00265109` - Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder	Phase 4
Recruiting	`NCT04373629` - Perceptual Abnormalities and Their Malleability in BDD	N/A
Completed	`NCT01453439` - Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder	N/A
Completed	`NCT00871143` - Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD)	N/A
Completed	`NCT00106223` - Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder	N/A
Active, not recruiting	`NCT00211809` - CBT as an Adjunct to SRIs in the Treatment of BDD	Phase 4